You're Doing Keto Right, Yet Not Losing Weight. Here's Why.

FTO’s primary job is to regulate appetite signaling in the brain’s hunger centers, particularly in the hypothalamus. When working normally, FTO helps send satiety signals that tell you when to stop eating. It also influences whether you naturally crave high-fat, calorie-dense foods or find them easy to moderate.

The FTO rs9939609 A allele, carried by roughly 45% of people with European ancestry, significantly impairs this appetite-signaling function. People with the A allele experience weaker satiety signals, which means they feel hungry sooner after eating and find high-fat foods more rewarding and harder to resist. On a ketogenic diet, where fat intake is deliberately very high, this becomes a critical problem: your brain never fully receives the “full” signal.

On keto, this manifests as constant hunger despite eating sufficient calories, cravings that feel impossible to ignore, and a tendency to overeat at meals without realizing it. You might find yourself eating past the point of comfortable fullness because your satiety signals are genuinely blunted.

PPARG is a master regulator of fat storage and glucose metabolism. It controls how efficiently your fat cells take up and store triglycerides, and how sensitive those cells are to hormones like insulin. When PPARG is working optimally, fat is stored and mobilized in response to energy needs. The Pro12 variant is the ancestral form carried by roughly 75% of people, while the Ala12 variant, carried by about 25%, is considered more metabolically favorable.

Here’s the critical issue: the Pro12 allele promotes extremely efficient fat storage. People with the Pro12/Pro12 genotype have fat cells that are particularly good at taking up and storing triglycerides, which means their body’s default setting is “store this fat, don’t release it.” This variant is particularly problematic on low-fat diets, where insulin remains elevated and fat storage hormones are active. But on keto, where you’re eating high fat and trying to trigger fat mobilization, this becomes your metabolic disadvantage.

You might feel like you’re following keto perfectly, maintaining ketosis, yet your body stubbornly refuses to tap into stored fat. The scale doesn’t move because your genes make your fat cells preferentially store incoming fat rather than release existing stores for energy.

The ADRB2 gene encodes the beta-2 adrenergic receptor, which sits on the surface of fat cells and responds to the hormone norepinephrine. When norepinephrine binds to this receptor during exercise, fasting, or stress, it triggers lipolysis: the breakdown and release of stored fat for energy. ADRB2 is your fat cell’s on-off switch for mobilizing energy.

The Gln27Glu and Arg16Gly variants in ADRB2, present in roughly 40% of the population, reduce the fat cell’s responsiveness to norepinephrine signaling. People with these variants have fat cells that are less efficient at responding to signals to release stored fat, meaning less fat is mobilized during exercise, fasting, or any metabolic stress. The signal is being sent, but your fat cells simply don’t listen as effectively.

On keto, this means you might feel like you’re in a fasted state, burning fat, getting stronger in the gym, but your actual fat mobilization is dampened. You’re not getting the fat-loss advantage that others experience, even though you’re doing the same protocol. Your fat cells are simply not as responsive to the hormonal signals telling them to release stored energy.

TCF7L2 is a transcription factor that regulates insulin secretion from the pancreas in response to blood glucose and incretin hormones. It’s one of the most well-studied genes in metabolic disease because it has such a profound effect on glucose control. When TCF7L2 is functioning well, your pancreas secretes just enough insulin to bring blood sugar down without overshooting.

The TCF7L2 rs7903146 T allele, carried by roughly 30% of the population, is the strongest common genetic risk factor for type 2 diabetes discovered to date. People with T alleles have impaired incretin-stimulated insulin secretion, which means their pancreas doesn’t respond efficiently to blood sugar rises, leading to higher fasting glucose, delayed insulin response, and ultimately higher baseline insulin levels. This is metabolic dysfunction at the foundational level.

On keto, where carbohydrate intake is minimal, this might seem less relevant. But it matters profoundly: people with TCF7L2 T alleles have inherently higher insulin resistance and metabolic dysfunction. Even in ketosis, their baseline insulin is higher, which suppresses fat mobilization and makes weight loss harder. They’re fighting an uphill metabolic battle that low carb alone cannot fully override.

MTHFR encodes methylenetetrahydrofolate reductase, an enzyme that catalyzes a critical step in the methylation cycle. This cycle is fundamental to cellular function: it supports energy production, detoxification, neurotransmitter synthesis, and crucially, lipid metabolism. When MTHFR works optimally, your cells have the methylated compounds they need to function efficiently at every level.

The MTHFR C677T variant, carried by roughly 40% of people with European ancestry, reduces enzyme activity by 40-70%. This impairs methylation-dependent metabolic processes throughout your body, including the breakdown of homocysteine and the support of fat metabolism. Your cells are essentially operating at reduced metabolic efficiency; energy production is slower, and fat mobilization is compromised at the biochemical level.

On keto, this manifests as lower overall energy, slower fat mobilization despite being in ketosis, and sometimes worsening of metabolism-dependent symptoms like brain fog or fatigue. You have the diet strategy right, but your cells lack the methylated nutrients they need to execute fat-burning efficiently. It’s not that keto doesn’t work; it’s that your fundamental cellular metabolism is running on a dimmer switch.

Wait, this is CLOCK, not ADRB2. Let me correct this.

CLOCK encodes a circadian clock protein that regulates the daily rhythm of metabolic gene expression. Your metabolism isn’t static throughout the day: it follows a circadian pattern where certain times are optimized for fat burning, nutrient uptake, and hormone secretion. CLOCK synchronizes this rhythm with your sleep-wake cycle and meal timing. When CLOCK works optimally, your metabolic efficiency aligns with when you eat and when you sleep.

The CLOCK 3111T/C variant (rs1801260), present in roughly 30-50% of the population, disrupts this circadian synchronization of metabolic genes. People with the C allele have impaired circadian regulation of metabolism, which means eating at the wrong circadian times causes greater metabolic dysregulation, higher weight gain, and worse metabolic efficiency. Your body is essentially out of sync with feeding and fasting cycles.

On keto, this becomes particularly problematic if you’re eating late in the day or skipping breakfast without considering your own circadian rhythm. Even in ketosis, if your meals are coming at times when your metabolic genes are downregulated, you’re fighting your circadian biology. The same keto protocol might work perfectly if timed with your circadian peaks and fail completely if timed against them.